Therapy assessment in multiple myeloma with PET

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Multiple myeloma is a plasma cell cancer causing bone lesions.
• Effective therapy assessment is crucial due to diverse treatment options.
• Imaging, particularly FDG PET/CT, is vital for evaluating treatment response.

Purpose of the Study:

• To review the role of FDG PET/CT in assessing multiple myeloma treatment efficacy.
• To highlight the prognostic value of FDG PET/CT in multiple myeloma management.
• To identify current limitations and future directions in PET imaging for multiple myeloma therapy assessment.

Main Methods:

• Literature review of studies evaluating FDG PET/CT in multiple myeloma.
• Analysis of prognostic data derived from FDG PET/CT.
• Discussion of challenges in image interpretation and standardization.

Main Results:

• FDG PET/CT provides reliable and safe prognostic information for multiple myeloma.
• Concordant results exist regarding FDG PET/CT's value in therapy assessment.
• Standardization of interpretation, especially for borderline findings, remains a challenge.

Conclusions:

• FDG PET/CT is a valuable tool for monitoring multiple myeloma treatment response.
• Further research is needed to standardize interpretation and explore advanced imaging like PET/MR.
• Consistent application of FDG PET/CT can improve patient management and outcomes.